Canada - TSX:TSND - CA88105E1088 - Common Stock
The current stock price of TSND.CA is 1.02 CAD. In the past month the price decreased by -11.3%. In the past year, price decreased by -19.68%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.79 | 3.54B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 2.03B | ||
| CRON.CA | CRONOS GROUP INC | 25.07 | 1.34B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.1 | 842.75M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 621.01M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 571.64M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 358.88M | ||
| HITI.CA | HIGH TIDE INC | N/A | 362.88M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 21.23 | 344.10M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 310.30M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 249.59M | ||
| XLY.CA | AUXLY CANNABIS GROUP INC | 6 | 242.69M |
TerrAscend Corp. produces and sells medical cannabis products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2017-05-03. The firm has vertically integrated operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through its subsidiary, TerrAscend Growth Corp., along with retail operations in Canada. The firm operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core market. The Company’s cultivation and production methods deliver cannabis, offerring a diverse range of products for both medical and legal adult-use consumers. The company has a variety of product types, including flowers, vaporizable, concentrations, topicals, tinctures, and edibles. The firm owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. The company also operates a cannabis dispensary located in Goshen Township, Ohio.
TERRASCEND CORP
3610 Mavis Road
Mississauga ONTARIO CA
Employees: 742
Phone: 18558377295
TerrAscend Corp. produces and sells medical cannabis products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2017-05-03. The firm has vertically integrated operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through its subsidiary, TerrAscend Growth Corp., along with retail operations in Canada. The firm operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core market. The Company’s cultivation and production methods deliver cannabis, offerring a diverse range of products for both medical and legal adult-use consumers. The company has a variety of product types, including flowers, vaporizable, concentrations, topicals, tinctures, and edibles. The firm owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. The company also operates a cannabis dispensary located in Goshen Township, Ohio.
The current stock price of TSND.CA is 1.02 CAD. The price decreased by -10.53% in the last trading session.
TSND.CA does not pay a dividend.
TSND.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
TSND.CA stock is listed on the Toronto Stock Exchange exchange.
TERRASCEND CORP (TSND.CA) has a market capitalization of 377.13M CAD. This makes TSND.CA a Small Cap stock.
ChartMill assigns a technical rating of 3 / 10 to TSND.CA. When comparing the yearly performance of all stocks, TSND.CA is a bad performer in the overall market: 89.94% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to TSND.CA. TSND.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months TSND.CA reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS decreased by -12.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.33% | ||
| ROE | -64.65% | ||
| Debt/Equity | 1.77 |
9 analysts have analysed TSND.CA and the average price target is 1.96 CAD. This implies a price increase of 91.67% is expected in the next year compared to the current price of 1.02.
For the next year, analysts expect an EPS growth of 55.61% and a revenue growth -13.46% for TSND.CA